Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-08-03

Clinical Trial Update: Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the efficacy and safety of levetiracetam versus placebo for levodopa-induced dyskinesias in advanced Parkinson's disease. The study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED